ArticleBMC public health2025
Dynapenic abdominal obesity and the risks of heart disease and all-cause mortality: a 7-year longitudinal study among middle-aged and older Chinese adults.
Article in BMC public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed.
- Dynapenic Abdominal Obesity and Disability in Middle-Aged and Older Adults: A Systematic Review and Meta-Analysis of Prospective Cohort Studies.Healthcare (Basel, Switzerland) · 2026Review
- Association between dynamic abdominal obesity (DAO) and benign prostatic hyperplasia (lower urinary tract symptoms): evidence from the China Health and Retirement Longitudinal Study (CHARLS).World journal of urology · 2026Article
- The prevalence and influencing factors of dynapenia among middle-aged and elderly individuals with knee osteoarthritis: a cross-sectional analysis.BMC musculoskeletal disorders · 2026Article
- Longitudinal prevalence and correlates of dynapenic abdominal obesity among community-dwelling ageing adults in rural South Africa from 2015 to 2022.Scientific reports · 2026Article
- Integrating Evidence on Dynapenia and Dynapenic Obesity: An Umbrella Review of Health Outcomes Among Community-Dwelling Older Adults.Healthcare (Basel, Switzerland) · 2026Review
- Dynapenic Abdominal Obesity and the Risk of Non-Neoplastic Digestive System Diseases in Postmenopausal Women: A Prospective Cohort Study.International journal of women's health · 2026Article
- Dynapenic Abdominal Obesity and the Risk of Stroke in Postmenopausal Women.International journal of women's health · 2026Article
- Dynapenic abdominal obesity and elevated risk of multidimensional multimorbidity across physical, psychological, and cognitive domains: evidence from longitudinal cohorts.Environmental health and preventive medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundResearch on the impact of dynapenic abdominal obesity (DAO) on heart disease and mortality in Asian populations is limited. Given the distinct muscle strength and visceral adiposity profiles in Asians compared to other populations, it is important to investigate these associations in this context. This study aimed to assess the impact of DAO on heart disease and all-cause mortality in middle-aged and older Chinese adults.
methodsData were obtained from the China Health and Retirement Longitudinal Study (CHARLS), which recruited 17,708 participants at baseline and followed them for 7 years. DAO was defined as the coexistence of dynapenia (handgrip strength < 28 kg for men and < 18 kg for women) and abdominal obesity (waist circumference ≥ 90 cm for men and ≥ 80 cm for women). Participants were categorized into four groups: DAO, non-dynapenic/abdominal obesity (ND/AO), dynapenic/non-abdominal obesity (D/NAO), and neither condition (ND/NAO). Logistic regression assessed the association between DAO and heart disease, while Cox regression evaluated its relationship with all-cause mortality. Additionally, subgroup analyses explored potential variations by age and sex. For sensitivity analyses, multiple imputation was performed to address missing covariates and assess the robustness of the findings.
resultsA total of 8,526 participants were included in the heart disease analysis, with 1,136 incident cases recorded. Compared to the ND/NAO group, the DAO group did not exhibit a significantly increased risk of heart disease (OR = 0.96, 95% CI: 0.68-1.33). For all-cause mortality analysis, 11,980 individuals were included, with 1,162 deaths occurred during follow-up. The DAO group (HR = 1.84, 95% CI: 1.45-2.33) and D/NAO group (HR = 1.58, 95% CI: 1.35-1.86) had significantly higher all-cause mortality risk compared to the reference group. Subgroup analyses found no significant interactions by age or sex. Sensitivity analyses produced consistent results for both incident heart disease and all-cause mortality.
conclusionsDAO was associated with increased all-cause mortality in middle-aged and older Chinese adults, highlighting the need for targeted interventions to address both abdominal obesity and dynapenia. However, the lack of association with heart disease, likely due to confounding factors, warrants further investigation to clarify this relationship.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.